FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2738263035> ?p ?o ?g. }

• W2738263035 endingPage "115" @default.
• W2738263035 startingPage "108" @default.
• W2738263035 abstract "In non-small cell lung cancer (NSCLC), platelet-derived growth factor receptor (PDGFR) mediates angiogenesis, tissue invasion, and tumor interstitial pressure. Olaratumab (IMC-3G3) is a fully human anti-PDGFRα monoclonal antibody. This Phase II study assessed safety and efficacy of olaratumab+paclitaxel/carboplatin (P/C) versus P/C alone for previously untreated advanced NSCLC.Patients received up to six 21-day cycles of P 200mg/m2 and C AUC 6 (day 1)±olaratumab 15mg/kg (days 1 and 8). Primary endpoint was PFS. Olaratumab was continued in the olaratumab+P/C arm until disease progression.131 patients were: 67 with olaratumab+P/C and 64 with P/C; 74% had nonsquamous NSCLC. Median PFS was similar between olaratumab+P/C and P/C (4.4 months each) (HR 1.29; 95% CI [0.86-1.93]; p=0.21). Median OS was similar between olaratumab+P/C (11.8 months) and P/C (11.5 months) (HR 1.04; 95% CI [0.68-1.57]; p=0.87). Both arms had similar toxicity profiles. All evaluable cases were PDGFR-negative by immunohistochemistry. Tumor stroma PDGFR expression was evaluable in 23/131 patients, of which 78% were positive.The addition of olaratumab to P/C did not result in significant prolongation of PFS or OS in advanced NSCLC. Olaratumab studies in other patient populations, including soft tissue sarcoma (NCT02783599), pancreatic cancer (NCT03086369), and pediatric malignancies (NCT02677116) are underway." @default.
• W2738263035 created "2017-07-31" @default.
• W2738263035 creator A5002170706 @default.
• W2738263035 creator A5013985547 @default.
• W2738263035 creator A5031684939 @default.
• W2738263035 creator A5036587861 @default.
• W2738263035 creator A5048281465 @default.
• W2738263035 creator A5049306094 @default.
• W2738263035 creator A5052477552 @default.
• W2738263035 creator A5055537555 @default.
• W2738263035 creator A5062111389 @default.
• W2738263035 creator A5072962574 @default.
• W2738263035 creator A5087619437 @default.
• W2738263035 creator A5091544328 @default.
• W2738263035 date "2017-09-01" @default.
• W2738263035 modified "2023-10-18" @default.
• W2738263035 title "Phase II study of olaratumab with paclitaxel/carboplatin (P/C) or P/C alone in previously untreated advanced NSCLC" @default.
• W2738263035 cites W1537640166 @default.
• W2738263035 cites W1948282121 @default.
• W2738263035 cites W1971343062 @default.
• W2738263035 cites W1982488143 @default.
• W2738263035 cites W1986049650 @default.
• W2738263035 cites W1996515934 @default.
• W2738263035 cites W2005724828 @default.
• W2738263035 cites W2013540568 @default.
• W2738263035 cites W2017210417 @default.
• W2738263035 cites W2019607817 @default.
• W2738263035 cites W2041484496 @default.
• W2738263035 cites W2056574134 @default.
• W2738263035 cites W2063084845 @default.
• W2738263035 cites W2074644169 @default.
• W2738263035 cites W2076812945 @default.
• W2738263035 cites W2079117904 @default.
• W2738263035 cites W2087630768 @default.
• W2738263035 cites W2093775484 @default.
• W2738263035 cites W2100785570 @default.
• W2738263035 cites W2104347254 @default.
• W2738263035 cites W2104830962 @default.
• W2738263035 cites W2111662961 @default.
• W2738263035 cites W2116991471 @default.
• W2738263035 cites W2121191052 @default.
• W2738263035 cites W2131862721 @default.
• W2738263035 cites W2138088489 @default.
• W2738263035 cites W2139248078 @default.
• W2738263035 cites W2140626630 @default.
• W2738263035 cites W2140922568 @default.
• W2738263035 cites W2145835533 @default.
• W2738263035 cites W2151200446 @default.
• W2738263035 cites W2161817637 @default.
• W2738263035 cites W2167599107 @default.
• W2738263035 cites W2169865627 @default.
• W2738263035 cites W2170030318 @default.
• W2738263035 cites W2170429308 @default.
• W2738263035 cites W2413552560 @default.
• W2738263035 cites W2560367415 @default.
• W2738263035 cites W2572174216 @default.
• W2738263035 doi "https://doi.org/10.1016/j.lungcan.2017.07.009" @default.
• W2738263035 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5672830" @default.
• W2738263035 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28838379" @default.
• W2738263035 hasPublicationYear "2017" @default.
• W2738263035 type Work @default.
• W2738263035 sameAs 2738263035 @default.
• W2738263035 citedByCount "11" @default.
• W2738263035 countsByYear W27382630352018 @default.
• W2738263035 countsByYear W27382630352019 @default.
• W2738263035 countsByYear W27382630352020 @default.
• W2738263035 countsByYear W27382630352021 @default.
• W2738263035 countsByYear W27382630352022 @default.
• W2738263035 countsByYear W27382630352023 @default.
• W2738263035 crossrefType "journal-article" @default.
• W2738263035 hasAuthorship W2738263035A5002170706 @default.
• W2738263035 hasAuthorship W2738263035A5013985547 @default.
• W2738263035 hasAuthorship W2738263035A5031684939 @default.
• W2738263035 hasAuthorship W2738263035A5036587861 @default.
• W2738263035 hasAuthorship W2738263035A5048281465 @default.
• W2738263035 hasAuthorship W2738263035A5049306094 @default.
• W2738263035 hasAuthorship W2738263035A5052477552 @default.
• W2738263035 hasAuthorship W2738263035A5055537555 @default.
• W2738263035 hasAuthorship W2738263035A5062111389 @default.
• W2738263035 hasAuthorship W2738263035A5072962574 @default.
• W2738263035 hasAuthorship W2738263035A5087619437 @default.
• W2738263035 hasAuthorship W2738263035A5091544328 @default.
• W2738263035 hasBestOaLocation W27382630352 @default.
• W2738263035 hasConcept C126322002 @default.
• W2738263035 hasConcept C126894567 @default.
• W2738263035 hasConcept C142724271 @default.
• W2738263035 hasConcept C143998085 @default.
• W2738263035 hasConcept C168563851 @default.
• W2738263035 hasConcept C203092338 @default.
• W2738263035 hasConcept C2776694085 @default.
• W2738263035 hasConcept C2778239845 @default.
• W2738263035 hasConcept C2778256501 @default.
• W2738263035 hasConcept C2778629024 @default.
• W2738263035 hasConcept C2780739268 @default.
• W2738263035 hasConcept C2781451048 @default.
• W2738263035 hasConcept C31760486 @default.
• W2738263035 hasConcept C71924100 @default.
• W2738263035 hasConceptScore W2738263035C126322002 @default.

• next